Assessing peripheral neuropathy

Thursday 18th February 2021

It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous about mentioning peripheral neuropathy, and often minimise its impact, as they are concerned that their treatment could be reduced or stopped.

GatewayC’s Managing Physical Effects course reviews the common side effects of cancer treatments and aims to help in the identification and management of some specific short- and long-term side effects, including peripheral neuropathy. This course features an interactive video consultation which demonstrates how a GP might assess the seriousness of the peripheral neuropathy of a colorectal cancer patient.

Find out more:

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: Myeloma and C.R.A.B

Cancer Keys: Myeloma and C.R.A.B

Myeloma and C.R.A.B C.R.A.B is the acronym designed to simplify the most typical clinical manifestations of multiple myeloma. Clinicians should consider the following indicators in a potential myeloma diagnosis: C: Calcium - hypercalcaemia R: Renal – any form of renal...

read more

Related Posts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.